Synektik CEO sells 7.2% stake for 215M zł after 1,500% share surge
What's the deal? Cezary Kozanecki, founder, chief executive officer, and largest shareholder of Polish medical equipment distributor SynektikDealroom has a profile for this one. Try Dealroom →, sold 615,000 shares — 7.2% of the company's share capital — for slightly over 215 million zł. The sale, executed on August 21 after the trading session, went to three undisclosed investors at 350 zł per share, 1.6% below Friday's close.
Why now? Kozanecki said several fund managers had encouraged him to sell part of his stake in recent months. He framed the move as personal: "The sale of part of Synektik shares is related to my personal needs." (translated from Polish)
What's the endgame? Kozanecki remains chief executive officer and largest shareholder with a 16.8% stake, and said he does not plan to sell more. Synektik shares have risen more than 1,500% since the company's debut on the Warsaw Stock Exchange main market a decade ago.
What does Synektik do? Its core business is distributing da Vinci surgical robots made by US group Intuitive Surgical, along with servicing and single-use parts. It holds exclusive distribution rights in Poland, the Czech Republic, Slovakia, and — recently — the Baltic states and Ukraine.
The company is also adding distribution of the Edison system from US firm HistoSonics, used for minimally invasive treatment of liver tumours, under an exclusive deal for Poland, the Czech Republic, Slovakia, and the Baltic states signed earlier this year.
By the numbers: Third-quarter revenue for the 2025/26 financial year, ending in June, rose 89% to 292.3 million zł, with net profit up 80% to 55.1 million zł and EBITDA from continuing operations up 72% to 71.5 million zł.
Over nine months, revenue reached 733.4 million zł and EBITDA 189.6 million zł. Continuing operations delivered 138 million zł of net profit, up 61% year on year.
The signal: Kozanecki's exit follows larger sales by Mariusz Książek, known from developer MarvipolDealroom has a profile for this one. Try Dealroom →, who offloaded 16.13% at 300 zł in June and 10% at 225 zł earlier in 2025. The steadily rising prices point to strong demand for Synektik stock even as founding backers cash out.
Read more: Puls Biznesu
Image credit: Generated with Gemini
